umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Optimizing Management of Heart Failure by Using Echo and Natriuretic Peptides in the Outpatient Unit
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine. Clinic of Cardiology, University Clinical Centre of Kosova,Prishtina, Kosovo.
Show others and affiliations
2018 (English)In: Heart Failure: From Research to Clinical Practice: vol 3 / [ed] Islam, Shahidul, Springer Publishing Company, 2018, p. 145-159Chapter in book (Refereed)
Abstract [en]

Chronic heart failure (HF) is an important public health problem and is associated with high morbidity, high mortality, and considerable healthcare costs. More than 90% of hospitalizations due to worsening HF result from elevations of left ventricular (LV) filling pressures and fluid overload, which are often accompanied by the increased synthesis and secretion of natriuretic peptides (NPs). Furthermore, persistently abnormal LV filling pressures and a rise in NP circulating levels are well known indicators of poor prognosis. Frequent office visits with the resulting evaluation and management are most often needed. The growing pressure from hospital readmissions in HF patients is shifting the focus of interest from traditionally symptom-guided care to a more specific patient-centered follow-up care based on clinical findings, BNP and echo. Recent studies supported the value of serial NP measurements and Doppler echocardiographic biomarkers of elevated LV filling pressures as tools to scrutinize patients with impending clinically overt HF. Therefore, combination of echo and pulsed-wave blood-flow and tissue Doppler with NPs appears valuable in guiding ambulatory HF management, since they are potentially useful to distinguish stable patients from those at high risk of decompensation.

Place, publisher, year, edition, pages
Springer Publishing Company, 2018. p. 145-159
Series
Advances in Experimental Medicine and Biology, ISSN 0065-2598 ; 1067
Keywords [en]
Heart failure, Natriuretic peptides, Pulmonary capillary wedge pressure, Echocardiography, Ejection fraction, Diastolic dysfunction, Prognosis, Hemodynamic profiles, Cardiac output
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:umu:diva-157336DOI: 10.1007/5584_2017_137ISI: 000458005400010PubMedID: 29374825ISBN: 978-3-3197-8280-5 (electronic)ISBN: 978-3-319-78279-9 (print)OAI: oai:DiVA.org:umu-157336DiVA, id: diva2:1297049
Available from: 2019-03-19 Created: 2019-03-19 Last updated: 2019-03-19Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Bajraktari, Gani

Search in DiVA

By author/editor
Bajraktari, GaniMumoli, Nicola
By organisation
Department of Public Health and Clinical Medicine
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
isbn
urn-nbn

Altmetric score

doi
pubmed
isbn
urn-nbn
Total: 25 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf